Smiths Medical

Smiths Medical is a global manufacturer of medical devices, offering vital solutions (syringes, infusion systems, etc.) for hospitals, emergency care, home and specialized conditions.

History

2022

Recall of defective syringe infusion pumps after death data due to them

In late July 2022, Smiths Medical announced the recall of defective Medfusion 3500 and 4000 syringe infusion pumps after the company obtained data on trams and deaths due to these products. Read more here.

ICU Medical bought Smiths Medical for $2.35 billion

On January 6, 2022, ICU Medical announced the completion of the acquisition of Smiths Medical from Smiths Group for $2.35 billion. Combined with existing ICU Medical facilities, the combined companies form an infusion therapy company with an estimated combined revenue of approximately $2.5 billion.

Smiths Medical's business includes syringes and outpatient infusion devices and other vital products for patients. British ICU Medical made a previous offer to buy Smiths Medical for $4 billion, which the company rejected, and at the end of 2018, the Smiths Group announced the start of merger negotiations.

ICU Medical Acquires Smiths Medical for $2.35 Billion

We are pleased that Smiths Medical is now part of ICU Medical and welcome our new Smiths colleagues to the ICU team. We look forward to working together to continue to deliver quality, innovation and value to our clinical clients around the world! The addition of Smiths Medical fits well with ICU Medical's existing business and creates a massive global competitor in the US that enhances the stability of the medical supply chain and can grow as clinical care models evolve, said ICU Medical CEO Vivek Jain.

The acquisition attracts significant investment in integration and infrastructure designed to support the 2017 acquisition of Hospira Infusion Systems. This will allow ICU Medical to build on a corporate culture that creates value through accountability, transparent action, making quick and informed decisions, and maintaining concentration to meet customer needs.^[1]

2021

Recall of 0.5 million defective devices for heating blood and infusion solutions

In mid-September 2021, Smiths Medical announced the recall of 0.5 million Normoflo heaters and irrigation fluid kits due to the possibility of aluminum ions entering heated fluids. Read more here.

Recall of defective insulin syringes

In mid-June 2021, the American company Smiths Medical recalled its Jelco Hypodermic Needle-Pro fixed-needle insulin syringes. The recall was categorized as a Class 1 group because the disorders identified could threaten the life and health of patients. Read more here.